Display Settings:

Format

Send to:

Choose Destination

    Infect Immun. 2006 Jan;74(1):773-6.

    Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

    Polley R, Stager S, Prickett S, Maroof A, Zubairi S, Smith DF, Kaye PM.

    Immunology and Infection Unit, Dept. of Biology, University of York, P.O. Box 373, York YO10 5YW, United Kingdom.

    CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.

    PMID: 16369038 [PubMed - indexed for MEDLINE]

    PMCID: 1346645

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read